Newsletters

MM&M KOL White Paper

MM&M KOL (Key Opinion Leaders) White Paper, a free e-newsletter giving readers an opportunity to benefit from the insights, knowledge and experience of key opinion leaders in the industry.

MM&M News Brief

MM&M News Brief delivers up-to-the-minute news alerts, stories and analysis to the healthcare marketing and communications sector, four days a week. News topics will span the full spectrum of MM&M’s coverage.

MM&M Sponsored Promotion

MM&M Sponsored Promotion provides over 70,000 healthcare manufacturing professionals, including key decision-makers within pharma, biotech and medical device manufacturing, with timely updates on New Product Launches, Webcasts, Conferences & Events, Special Announcements and more.

MM&M Weekly Digest

MM&M Weekly Digest offers a roundup of the week’s big stories, people moves and notable developments in healthcare marketing, along with links to special reports and useful information from MM&M.

The Splash from MM&M

The Splash from MM&M - monthly feature article emailed out to subscribers highlighting the feature article i.e. MM&M All Stars, Patient Marketing Report, etc. The concept is a “newsletter that presents the cover story each month with a bit of text directing readers to the site”. It would carry display advertising and a text ad.

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.